Combining immunotherapy with radiation for the treatment of glioblastoma

Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuro-oncology 2015-07, Vol.123 (3), p.459-464
Hauptverfasser: Chow, Kevin K. H., Hara, Wendy, Lim, Michael, Li, Gordon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 464
container_issue 3
container_start_page 459
container_title Journal of neuro-oncology
container_volume 123
creator Chow, Kevin K. H.
Hara, Wendy
Lim, Michael
Li, Gordon
description Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.
doi_str_mv 10.1007/s11060-015-1762-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1709189807</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1695759969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</originalsourceid><addsrcrecordid>eNqFkU1rGzEQQEVJaBy3P6CXspBLL9to9DWrYzFJXTD04kNuQuvV2jK7K1fSEvLvs46dUAqhJx3mzRvEI-QL0O9AKd4mAKpoSUGWgIqV-gOZgUReIkd-QWYUFJZSi4crcp3SnlIqkMNHcsVkhShUNSPLRehrP_hhW_i-H4eQdy7aw1Px6POuiLbxNvswFG2IxTQqcnQ2927IRWiLbedD3dmUQ28_kcvWdsl9Pr9zsr6_Wy-W5er3z1-LH6tyI1DmUgADxVACR9GClE1VQ1WJ1mloeKMl5cA0Nli3grGNqFTtVM2cELrltdR8Tr6dtIcY_owuZdP7tHFdZwcXxmQAqYZKVxT_jyotUWqtjtabf9B9GOMw_eOFAs6Q0YmCE7WJIaXoWnOIvrfxyQA1xyDmFMRMQcwxiDmav57NY9275m3jtcAEsBOQptGwdfGv0-9anwGfdpP6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1695132720</pqid></control><display><type>article</type><title>Combining immunotherapy with radiation for the treatment of glioblastoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Chow, Kevin K. H. ; Hara, Wendy ; Lim, Michael ; Li, Gordon</creator><creatorcontrib>Chow, Kevin K. H. ; Hara, Wendy ; Lim, Michael ; Li, Gordon</creatorcontrib><description>Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-015-1762-9</identifier><identifier>PMID: 25877468</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Brain Neoplasms - immunology ; Brain Neoplasms - therapy ; Combined Modality Therapy ; Editors' Invited Manuscript ; Glioblastoma - immunology ; Glioblastoma - therapy ; Humans ; Immunotherapy - methods ; Medicine ; Medicine &amp; Public Health ; Neurology ; Oncology ; Radiotherapy - methods</subject><ispartof>Journal of neuro-oncology, 2015-07, Vol.123 (3), p.459-464</ispartof><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</citedby><cites>FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-015-1762-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-015-1762-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25877468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chow, Kevin K. H.</creatorcontrib><creatorcontrib>Hara, Wendy</creatorcontrib><creatorcontrib>Lim, Michael</creatorcontrib><creatorcontrib>Li, Gordon</creatorcontrib><title>Combining immunotherapy with radiation for the treatment of glioblastoma</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.</description><subject>Brain Neoplasms - immunology</subject><subject>Brain Neoplasms - therapy</subject><subject>Combined Modality Therapy</subject><subject>Editors' Invited Manuscript</subject><subject>Glioblastoma - immunology</subject><subject>Glioblastoma - therapy</subject><subject>Humans</subject><subject>Immunotherapy - methods</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurology</subject><subject>Oncology</subject><subject>Radiotherapy - methods</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1rGzEQQEVJaBy3P6CXspBLL9to9DWrYzFJXTD04kNuQuvV2jK7K1fSEvLvs46dUAqhJx3mzRvEI-QL0O9AKd4mAKpoSUGWgIqV-gOZgUReIkd-QWYUFJZSi4crcp3SnlIqkMNHcsVkhShUNSPLRehrP_hhW_i-H4eQdy7aw1Px6POuiLbxNvswFG2IxTQqcnQ2927IRWiLbedD3dmUQ28_kcvWdsl9Pr9zsr6_Wy-W5er3z1-LH6tyI1DmUgADxVACR9GClE1VQ1WJ1mloeKMl5cA0Nli3grGNqFTtVM2cELrltdR8Tr6dtIcY_owuZdP7tHFdZwcXxmQAqYZKVxT_jyotUWqtjtabf9B9GOMw_eOFAs6Q0YmCE7WJIaXoWnOIvrfxyQA1xyDmFMRMQcwxiDmav57NY9275m3jtcAEsBOQptGwdfGv0-9anwGfdpP6</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Chow, Kevin K. H.</creator><creator>Hara, Wendy</creator><creator>Lim, Michael</creator><creator>Li, Gordon</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20150701</creationdate><title>Combining immunotherapy with radiation for the treatment of glioblastoma</title><author>Chow, Kevin K. H. ; Hara, Wendy ; Lim, Michael ; Li, Gordon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-412162751374f155d8b1884fe91d3d95031297d7bf422c486be6b2e449f3b593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Brain Neoplasms - immunology</topic><topic>Brain Neoplasms - therapy</topic><topic>Combined Modality Therapy</topic><topic>Editors' Invited Manuscript</topic><topic>Glioblastoma - immunology</topic><topic>Glioblastoma - therapy</topic><topic>Humans</topic><topic>Immunotherapy - methods</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurology</topic><topic>Oncology</topic><topic>Radiotherapy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chow, Kevin K. H.</creatorcontrib><creatorcontrib>Hara, Wendy</creatorcontrib><creatorcontrib>Lim, Michael</creatorcontrib><creatorcontrib>Li, Gordon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chow, Kevin K. H.</au><au>Hara, Wendy</au><au>Lim, Michael</au><au>Li, Gordon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combining immunotherapy with radiation for the treatment of glioblastoma</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>123</volume><issue>3</issue><spage>459</spage><epage>464</epage><pages>459-464</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>Glioblastoma is a devastating cancer with universally poor outcomes in spite of current standard multimodal therapy. Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side effect profile; however, clinical trials of immunotherapy in GBM have thus far shown modest benefit. Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence that radiation can enhance anti-tumor immunity. Here we review this evidence and discuss considerations for combined therapy.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25877468</pmid><doi>10.1007/s11060-015-1762-9</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-594X
ispartof Journal of neuro-oncology, 2015-07, Vol.123 (3), p.459-464
issn 0167-594X
1573-7373
language eng
recordid cdi_proquest_miscellaneous_1709189807
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Brain Neoplasms - immunology
Brain Neoplasms - therapy
Combined Modality Therapy
Editors' Invited Manuscript
Glioblastoma - immunology
Glioblastoma - therapy
Humans
Immunotherapy - methods
Medicine
Medicine & Public Health
Neurology
Oncology
Radiotherapy - methods
title Combining immunotherapy with radiation for the treatment of glioblastoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A56%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combining%20immunotherapy%20with%20radiation%20for%20the%20treatment%20of%20glioblastoma&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Chow,%20Kevin%20K.%20H.&rft.date=2015-07-01&rft.volume=123&rft.issue=3&rft.spage=459&rft.epage=464&rft.pages=459-464&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-015-1762-9&rft_dat=%3Cproquest_cross%3E1695759969%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1695132720&rft_id=info:pmid/25877468&rfr_iscdi=true